Ledger.Open graph →
SEC Form D · filed January 28, 2021

TScan Therapeutics, Inc

Offering
$100.0M
Sold
$100.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Waltham, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Nandita Shangari · Waltham, MADirectorChristoph Westphal · Boston, MADirectorAndrew Hedin · Cambridge, MADirectorIttai Harel · Lexington, MADirectorTimothy Barberich · Boston, MADirectorTimothy Barberich · Framingham, MADirectorChristoph Westphal · Boston, MADirectorDavid Southwell · Boston, MAExec · DirectorBrian Silver · Waltham, MADirectorDoug Fambrough · Waltham, MADirectorDavid Southwell · Waltham, MAExec · DirectorIttai Harel · Waltham, MADirectorBrian Silver · New York, NYDirectorDoug Fambrough · Waltham, MADirectorAndrew Hedin · Cambridge, MADirectorNandita Shangari · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗